Clinical Trials Logo

Filter by:
NCT ID: NCT04766450 Recruiting - Clinical trials for Diabetic Neuropathies

Effect of High-Dose NAC on Patients With DPN

NAC
Start date: December 1, 2021
Phase: Phase 4
Study type: Interventional

The aim of the current study is to evaluate the efficacy and safety of high dose oral NAC (2400 mg/day divided into two doses) as an adjunct therapy on oxidative stress, inflammatory markers and clinical outcome in patients with type 2 diabetes suffering from diabetic peripheral neuropathy.

NCT ID: NCT04766177 Recruiting - Autism Clinical Trials

Role of Bumetanide in Treatment of Autism

Start date: January 1, 2021
Phase: Phase 3
Study type: Interventional

Role of bumetanide in Autism

NCT ID: NCT04765930 Recruiting - Melasma Clinical Trials

Combined Q-switched Nd:YAG Laser and Platelet Rich Plasma Versus Q- Switched Nd:YAG Laser Alone in Melasma

Start date: October 1, 2019
Phase: N/A
Study type: Interventional

Melasma is a common, acquired, esthetically disfiguring hypermelanosis of the face. Melasma is considered a disappointing challenge when treatment options are addressed. Diverse treatment modalities such as retinoic acid, hypo-pigmenting agents like hydroquinone, azelaic acid, and kojic acid, chemical peels, microdermabrasion, and lasers have been tried for the treatment of melasma. There is no universally proven therapy that induces and maintains remission of the condition. Q-switched: Nd YAG laser toning and platelet rich plasma (PRP) are promising treatments for melasma.The aim of this work is evaluate the efficacy and safety of combined PRP and Q-switched: NdYAG laser in the treatment of melasma using clinical assessment, in addition to assessment of Melanin Index and Erythema Index.

NCT ID: NCT04765917 Recruiting - Clinical trials for Cerebral Palsy, Spastic

Effect of Motor Imagery Training on Gait and Balance in Children With Spastic Hemiplegia

Start date: February 1, 2021
Phase: N/A
Study type: Interventional

This study aims to: - Investigate the effect of motor imagery training on gait kinematics in children with spastic hemiplegia. - Determine the effect of motor imagery training on balance in children with spastic hemiplegia. - Assess the effect of motor imagery training on trunk endurance in children with spastic hemiplegia.

NCT ID: NCT04765826 Recruiting - Vitiligo Clinical Trials

Comparison Between Systemic Steroids, Topical Steroids, or Calcineurin Inhibitors With Mini Punch Grafting in Treatment of Stable Non-segmental Vitiligo

Start date: January 25, 2021
Phase: N/A
Study type: Interventional

The study to compare the outcomes of mini punch grafting in patients with resistant stable non-segmental vitiligo already on narrowband ultraviolet B and receiving either no additional medication , systemic mini pulse (high and low dose) steroids, topical superpotent steroids once every other day , or daily tacrolimus ointment .in terms of the extent of repigmentation , frequency of reactivation and side effects.

NCT ID: NCT04765254 Recruiting - Covid19 Clinical Trials

COVID-19 Infection in Diabetic Patients

Start date: February 20, 2021
Phase:
Study type: Observational

It was observed during the last period of COVID-19 pandemic that diabetic patients had a worse prognosis and more deteriorated clinical features than other patients

NCT ID: NCT04764071 Recruiting - Stone, Kidney Clinical Trials

Ultra-Mini Versus Standard Percutaneous Nephrolithotomy For Management Of Renal Calculi. A Randomized Controlled Trial.

Start date: February 28, 2021
Phase: Phase 3
Study type: Interventional

Renal stones are one of the most common urological problems and there are multiple methods for their management such as percutaneous nephrolithotomy, mini and ultra-mini percutaneous nephrolithotomy, flexible ureteroscopy and laser lithotripsy, and extracorporeal shock wave lithotripsy. percutaneous nephrolithotomy is the treatment of choice for the management of renal calculi, in spite of the increasing stone clearance rate, the complication rate of this procedure is relatively higher.

NCT ID: NCT04761861 Recruiting - Schizophrenia Clinical Trials

Vildagliptin for Treatment of Antipsychotic-induced Dyslipidemia

Start date: February 16, 2021
Phase: Phase 2
Study type: Interventional

Almost all antipsychotics can induce dyslipidemia, but no treatment has been established. Vildagliptin can improve lipid levels in obese patients. The investigators conducted a randomized, placebo-controlled study to test the efficacy of vildagliptin for antipsychotic-induced dyslipidemia.

NCT ID: NCT04760600 Recruiting - Parasite IBS IBD Clinical Trials

Role of Parasitic Infection in Inflammatory Bowel Disease and Irritable Bowel Syndrome

Start date: June 2021
Phase:
Study type: Observational

Role of parasitic infection in Inflammatory bowel disease and Irritable bowel The burden of the parasitic disease is in-direct relation with the health and nutritional status of the host, inducing not only parasite-specific immunity but also can modify the host's immune responses . Many parasites can imitate inflammatory bowel disorders and some studies showed that infection with parasites can improve disorders like IBD or moderate the symptoms of inflammatory bowel disorders . Even though, many studies have shown that gastrointestinal infection is an important risk factor for the development of IBS

NCT ID: NCT04759937 Recruiting - Dysentery Amebic Clinical Trials

Immunochromatography Versus Microscopy for Diagnosis of Entamoeba Histolytica/Dispar Infection.

Start date: March 20, 2021
Phase:
Study type: Observational

Amoebiasis, an infection by the protozoan parasite Entamoeba histolytica is globally considered as the third leading parasitic cause of human mortality besides malaria and schistosomiasis. It is estimated that E. histolytica may infect half a billion people annually. Moreover, it was estimated that 100,000 patients per year died due to the clinical complications of the disease. Laboratory diagnosis of E. histolytica/dispar is usually achieved by microscopic detection of trophozoites or cysts in stool samples. Microscopy is time consuming and requires an experienced observer to identify the organism. Furthermore, it must be performed on three stool samples to increase sensitivity leading to decreased patient compliance and delay in the final diagnosis. Therefore, a few the commercially available copro-antigen assay have been developed for E. histolytica/dispar diagnosis including the enzyme immunoassay and non-enzymatic immunochromatographic (ICT) assays that do not depend on microscopy skills and increase laboratory efficiency by reducing time and cost. The aim of the study is: 1. to evaluate the efficacy of commercially available rapid immunochromatographic Copro-antigen assay (RIDA® QUICK Entamoeba) in comparison with conventional microscopic examination for the diagnosis of E. histolytica /dispar infection. 2. to estimate the prevalence of E. histolytica /dispar infection in outpatients in Sohag.